To see all protocols that comply with the WHO Essential Medicine List 
  1. Home
  2. Clinical resources
  3. Side effect and toxicity management
  4. Immunological

Management of immune-related adverse events (irAEs)

­
Download PDFOpens in new window
On this page
Expand all Collapse all Back to top

Version 2

Date Summary of changes
06/12/2016 Developed in consultation with eviQ Medical Oncology Reference Committees and Melanoma Institute Australia. Published on eviQ. Review in 1 year. 
31/05/2017 Transferred to new eviQ website. Version number changed to V.2.
04/07/2018 Reviewed at Medical Oncology Reference Committee meeting on 15 June 2018. Wording changed 'medical oncologist' to 'treating clinician' to incorporate immunotherapy use in haematology. Next review in 2 years

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. Use is subject to eviQ’s disclaimer available at www.eviQ.org.au

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

https://www.eviq.org.au/p/1993

01 Apr 2020